MedPage Today) — The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced.
Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory…
Read More
Policybanaoo.com No1 Insurance company in India